Evaluation of the Use of Single- and Multi-Magnification Convolutional Neural Networks for the Determination and Quantitation of Lesions in Nonclinical Pathology Studies.

Journal: Toxicologic pathology
Published Date:

Abstract

Digital pathology platforms with integrated artificial intelligence have the potential to increase the efficiency of the nonclinical pathologist's workflow through screening and prioritizing slides with lesions and highlighting areas with specific lesions for review. Herein, we describe the comparison of various single- and multi-magnification convolutional neural network (CNN) architectures to accelerate the detection of lesions in tissues. Different models were evaluated for defining performance characteristics and efficiency in accurately identifying lesions in 5 key rat organs (liver, kidney, heart, lung, and brain). Cohorts for liver and kidney were collected from TG-GATEs open-source repository, and heart, lung, and brain from internally selected R&D studies. Annotations were performed, and models were trained on each of the available lesion classes in the available organs. Various class-consolidation approaches were evaluated from generalized lesion detection to individual lesion detections. The relationship between the amount of annotated lesions and the precision/accuracy of model performance is elucidated. The utility of multi-magnification CNN implementations in specific tissue subtypes is also demonstrated. The use of these CNN-based models offers users the ability to apply generalized lesion detection to whole-slide images, with the potential to generate novel quantitative data that would not be possible with conventional image analysis techniques.

Authors

  • Jogile Kuklyte
    Deciphex, Dublin, Ireland.
  • Jenny Fitzgerald
    Deciphex, Dublin, Ireland.
  • Sophie Nelissen
    50148Janssen Pharmaceutica NV, Janssen R&D, Beerse, Belgium.
  • Haolin Wei
    Deciphex, 8818Dublin City University, Dublin, Ireland.
  • Aoife Whelan
    Deciphex, 8818Dublin City University, Dublin, Ireland.
  • Adam Power
    Deciphex, Dublin, Ireland.
  • Ajaz Ahmad
    Deciphex, 8818Dublin City University, Dublin, Ireland.
  • Martyna Miarka
    Deciphex, 8818Dublin City University, Dublin, Ireland.
  • Mark Gregson
    Deciphex, Dublin, Ireland.
  • Michael Maxwell
    Deciphex, 8818Dublin City University, Dublin, Ireland.
  • Ruka Raji
    Deciphex, 8818Dublin City University, Dublin, Ireland.
  • Joseph Lenihan
    Deciphex, 8818Dublin City University, Dublin, Ireland.
  • Eve Finn-Moloney
    Deciphex, 8818Dublin City University, Dublin, Ireland.
  • Mairin Rafferty
    OncoMark, Dublin, Ireland.
  • Maurice Cary
    Pathology Experts GmbH, Technologie Zentrum Witterswil, Witters, Switzerland.
  • Erio Barale-Thomas
    50148Janssen Pharmaceutica NV, Janssen R&D, Beerse, Belgium.
  • Donal O'Shea
    Deciphex, 8818Dublin City University, Dublin, Ireland.